Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:IRKO
Date6/2013
Raised$145M
Post IPO Valuation

General Information

Offices

Philadelphia, USA
One Kew Place
150 Rouse Boulevard
Philadelphia, PA, 19112
USA

People

Funding

DEBT TOTAL $75M
Debt, 11/2013
OrbiMed Advisors
$75M

Tags

Iroko Pharmaceuticals

In the short period since Iroko was founded in 2007, we have assembled a portfolio of proven pharmaceuticals, especially prescription pain medicines. Our goal has been to bring new life to these trusted products—new geographic markets, new indications, and new benefits through further development enabled by new technology.

We have already extended a distribution and sales network across more than 40 countries. And we have developed an industry-leading pipeline of nano-formulated lower-dose NSAIDs to address the need for new options in pain management.

Experience. Marketed products. A global presence. Innovation.

That’s Iroko. We’re an established company. And we’re hurrying to improve healthcare.

Recent Milestones

Videos

Screenshots

Iroko Pharmaceuticals screenshot
Above: Homepage
Uploaded: 6/19/13

Stock Price

Sources

  1. Iroko Pharmaceuticals Closes $75M Debt Facility (finsmes.com) [edit]
Edit This Page
Last Edited 11/22/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy